The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study
Authors
Keywords
Cancer treatment, Ovaries, Granulosa cells, Toxicity, Ovulation, Oocytes, Histology, Mouse models
Journal
PLoS One
Volume 11, Issue 4, Pages e0152872
Publisher
Public Library of Science (PLoS)
Online
2016-04-02
DOI
10.1371/journal.pone.0152872
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of Polyclonal FLT3 Tyrosine Kinase Domain Mutations during Sequential Therapy with Sorafenib and Sunitinib in FLT3-ITD-Positive Acute Myeloid Leukemia
- (2013) S. D. Baker et al. CLINICAL CANCER RESEARCH
- Kinase Inhibitors: Adverse Effects Related to the Endocrine System
- (2013) Maya B. Lodish JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Alison W. Loren et al. JOURNAL OF CLINICAL ONCOLOGY
- Persistent Complete Response After Single-agent Sunitinib Treatment in a Case of TFE Translocation Positive Relapsed Metastatic Pediatric Renal Cell Carcinoma
- (2012) Tanzina Chowdhury et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
- (2011) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models
- (2011) S. Broutin et al. CLINICAL CANCER RESEARCH
- Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
- (2011) Maryse Brassard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endocrine side effects of broad-acting kinase inhibitors
- (2010) Maya B Lodish et al. ENDOCRINE-RELATED CANCER
- Growth factors controlling ovarian functions
- (2010) Alexander V. Sirotkin JOURNAL OF CELLULAR PHYSIOLOGY
- Onset of Male Gynaecomastia in a Patient Treated with Sunitinib for Metastatic Renal Cell Carcinoma
- (2009) Pierluigi Ballardini et al. CLINICAL DRUG INVESTIGATION
- MAPK3/1 (ERK1/2) in Ovarian Granulosa Cells Are Essential for Female Fertility
- (2009) H.-Y. Fan et al. SCIENCE
- New developments in multitargeted therapy for patients with solid tumours
- (2008) C. Le Tourneau et al. CANCER TREATMENT REVIEWS
- VEGF blockade inhibits angiogenesis and reepithelialization of endometrium
- (2008) Xiujun Fan et al. FASEB JOURNAL
- Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty
- (2008) Stefania Mariani et al. LANCET
- Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia
- (2008) G Caocci et al. LEUKEMIA
- More on Ovarian Insufficiency with Imatinib
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Primary Ovarian Insufficiency Associated with Imatinib Therapy
- (2008) Constantinos Christopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolactin Receptor Signaling Is Essential for Perinatal Brown Adipocyte Function: A Role for Insulin-like Growth Factor-2
- (2008) Say Viengchareun et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now